Search research articles
Contact Us
Filters
Showing results (831-840 of 1,080) with videos related to
Page
of 108
Sort By:
Journal of Medicinal Chemistry
|
January 31, 2024
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate
Roman Belle, Hilal Saraç, Eidarus Salah, et al.
Alimentary Pharmacology & Therapeutics
|
January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group
J R Green, J A Gibson, G D Kerr, et al.
Chemical Science
|
April 29, 2017
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Guo-Bo Li, Martine I Abboud, Jürgen Brem, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2003
DNA bending and unbending by MutS govern mismatch recognition and specificity
Hong Wang, Yong Yang, Mark J Schofield, et al.
Molecular Phylogenetics and Evolution
|
February 13, 2001
The ITS-2 of the nuclear rDNA as a molecular marker for populations, species, and phylogenetic relationships in Triatominae (Hemiptera: Reduviidae), vectors of Chagas disease
A Marcilla, M D Bargues, J M Ramsey, et al.
Cell Reports. Physical Science
|
September 18, 2025
Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5
Fathima Hameed Cherilakkudy, Midhun George Thomas, Ann Varghese, et al.
Iscience
|
November 7, 2022
Activity-based probes trap early active intermediates during metacaspase activation
Vida Štrancar, Katarina P van Midden, Daniel Krahn, et al.
Kidney International
|
May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
Serafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
European Journal of Biochemistry
|
December 6, 2000
Oxidative degradation of bilirubin produces vasoactive compounds
K R Kranc, G J Pyne, L Tao, et al.
Journal of Molecular Biology
|
May 24, 2011
Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
Rasheduzzaman Chowdhury, Emily Flashman, Jasmin Mecinović, et al.
Page
of 108
Search research articles
Search
Showing results (831-840 of 1,080) with videos related to
Sort By:
Page
of 108
Journal of Medicinal Chemistry
|
January 31, 2024
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate
Roman Belle, Hilal Saraç, Eidarus Salah, et al.
Alimentary Pharmacology & Therapeutics
|
January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group
J R Green, J A Gibson, G D Kerr, et al.
Chemical Science
|
April 29, 2017
NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
Guo-Bo Li, Martine I Abboud, Jürgen Brem, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 25, 2003
DNA bending and unbending by MutS govern mismatch recognition and specificity
Hong Wang, Yong Yang, Mark J Schofield, et al.
Molecular Phylogenetics and Evolution
|
February 13, 2001
The ITS-2 of the nuclear rDNA as a molecular marker for populations, species, and phylogenetic relationships in Triatominae (Hemiptera: Reduviidae), vectors of Chagas disease
A Marcilla, M D Bargues, J M Ramsey, et al.
Cell Reports. Physical Science
|
September 18, 2025
Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5
Fathima Hameed Cherilakkudy, Midhun George Thomas, Ann Varghese, et al.
Iscience
|
November 7, 2022
Activity-based probes trap early active intermediates during metacaspase activation
Vida Štrancar, Katarina P van Midden, Daniel Krahn, et al.
Kidney International
|
May 17, 2017
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
Serafim Kiriakidis, Simon S Hoer, Natalie Burrows, et al.
European Journal of Biochemistry
|
December 6, 2000
Oxidative degradation of bilirubin produces vasoactive compounds
K R Kranc, G J Pyne, L Tao, et al.
Journal of Molecular Biology
|
May 24, 2011
Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
Rasheduzzaman Chowdhury, Emily Flashman, Jasmin Mecinović, et al.
Page
of 108